| Therapeutic potential of 1, 3, 4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's disease S Naseem, A Temirak, A Imran, S Jalil, S Fatima, P Taslimi, J Iqbal, ... RSC advances 13 (26), 17526-17535, 2023 | 7 | 2023 |
| Synthesis and biological evaluation of 2-nitrocinnamaldehyde derived thiosemicarbazones as urease inhibitors M Islam, A Khan, M Khan, SA Halim, S Ullah, J Hussain, A Al-Harrasi, ... Journal of Molecular Structure 1284, 135387, 2023 | 6 | 2023 |
| Synthesis of 3‐hydroxy‐2‐naphthohydrazide‐based hydrazones and their implications in diabetic management via in vitro and in silico approaches M Tasleem, S Ullah, SA Halim, I Urooj, N Ahmed, R Munir, A Khan, ... Archiv der Pharmazie 357 (2), 2300544, 2024 | 3 | 2024 |
| Synthesis of novel 3-hydroxy-2-naphthoic hydrazones as selective chemosensors for cyanide ions RD Alharthy, I Urooj, M Tasleem, M Khalid, MA Asghar, SI Khan, M Ajmal, ... RSC advances 13 (22), 15208-15221, 2023 | 3 | 2023 |
| Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/phosphodiesterase-1 and-3 inhibitors M Tasleem, J Pelletier, J Sévigny, Z Hussain, A Khan, A Al-Harrasi, ... International Journal of Biological Macromolecules 266, 131068, 2024 | | 2024 |
| Design, synthesis, and in vitro and in silico studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitors M Tasleem, S Ullah, A Khan, SN Mali, S Kumar, B Mathew, A Oneto, ... RSC advances 14 (30), 21355-21374, 2024 | | 2024 |
